ALEXION PHARMACEUTICALS, INC.'s Net Worth

$5.53 Million

Estimate Recalculated Sep 8, 2024 07:20PM EST

Who is ALEXION PHARMACEUTICALS, INC.?

ALEXION PHARMACEUTICALS, INC. has an estimated net worth of $5.53 Million. This is based on reported shares across multiple companies, which include Inozyme Pharma, Inc., and SYNAGEVA BIOPHARMA CORP.

SEC CIK

ALEXION PHARMACEUTICALS, INC.'s CIK is 0000899866

Past Insider Trading and Trends

2020 was ALEXION PHARMACEUTICALS, INC.'s most active year for acquiring shares with 1 total transactions. ALEXION PHARMACEUTICALS, INC.'s most active month to acquire stocks was the month of June. 2020 was ALEXION PHARMACEUTICALS, INC.'s most active year for disposing of shares, totalling 1 transactions. ALEXION PHARMACEUTICALS, INC.'s most active month to dispose stocks was the month of June. 2020 saw ALEXION PHARMACEUTICALS, INC. paying a total of $0.00 for 1,109,910 shares, this is the most they've acquired in one year. In 2020 ALEXION PHARMACEUTICALS, INC. cashed out on 8,294,360 shares for a total of $0.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Inozyme Pharma, Inc. (INZY) Snapshot price: $4.98

Investor

ALEXION PHARMACEUTICALS, INC. owns 1,109,910 units of Common Stock which is worth $5,527,351.80. In the year 2020 ALEXION PHARMACEUTICALS, INC. filed a total of 2 filings.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
∞
1.11M
—
—
1.11M
Jul 28
Form 3
—
0
—
—
0
No matching records found

SYNAGEVA BIOPHARMA CORP No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found